Clinical Trial Update: Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating epacadostat alone and in combination with pembrolizumab, with or without chemotherapy, in participants with advanced solid tumors inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Epacadostat (epacadostat)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED | Results posted: 2022-01-11